|
| |
connetics scleroderma Pages on BioPortfolio:
BioPortfolio - Connetics Corporation
Connetics has several other products in development: ConXn(R) (recombinant human relaxin H2) ("relaxin"), targeting scleroderma, organ fibrosis, ...
http://www.bioportfolio.com/biocorporate/2944-Connetics_Corp...
|
BioPortfolio - Immunobiological Laboratories hamburg
immunobiological laboratories Hamburg | rota yokohama wehr | Nasaleze Ltd | connetics scleroderma | list of companies in discovery building(whitefield . ...
http://www.bioportfolio.com/search/Immunobiological_Laborato...
|
BioPortfolio - Scleroderma
Scleroderma - BioPortfolio - Indepth. ... Connetics Corporation is focused on the acquisition, development and commercialization of marketed and ...
http://www.bioportfolio.com/indepth/Scleroderma.html...
|
BioPortfolio - the biotechnology, pharmaceutical, life science and ...
BioPortfolio the comprehensive website for data, information, search engine and services on biotechnology, pharmaceutical and healthcare research, ...
http://www.bioportfolio.com/...
|
Results from other life science and pharmaceutical sites:
BioPortfolio - Connetics Corporation
Connetics has several other products in development: ConXn(R) (recombinant human relaxin H2) ("relaxin"), targeting scleroderma, organ fibrosis, ...
http://www.bioportfolio.com/biocorporate/2944-Connetics_Corp...
|
Relaxin Connetics/Celltech Richard Jones
250935 Connetics reports positive phase II scleroderma results. .... 316043 Connetics initiates pivotal trial with Relaxin for scleroderma. ...
http://www.biomedcentral.com/content/pdf/cd-398363.pdf...
|
BioPortfolio - Immunobiological Laboratories hamburg
immunobiological laboratories Hamburg | rota yokohama wehr | Nasaleze Ltd | connetics scleroderma | list of companies in discovery building(whitefield . ...
http://www.bioportfolio.com/search/Immunobiological_Laborato...
|
Relaxin (Connetics/Celltech). [IDrugs. 2001] - PubMed Result
It was also under development by the companies for scleroderma, but development ... In addition, Connetics is conducting preclinical studies to evaluate the ...
http://www.ncbi.nlm.nih.gov/pubmed/16032483...
|
Cantab failure shows need for wide portfolio - Nature Biotechnology
... Connetics (Palo Alto, CA) lost almost 80% of its share price on pulling its experimental treatment for scleroderma—human recombinant relaxin—after phase ...
http://www.nature.com/nbt/journal/v18/n12/full/nbt1200_1238a...
|
BioWorld Today - Jun 6, 1997
Other News to Note · FDA Prohibits Mammalian Protein In Sheep, Cattle Feed · Connetics Reports Positive Phase II Results For Scleroderma Therapy ...
http://www.bioworld.com/servlet/com.accumedia.web.Dispatcher...
|
Journal of Investigative Dermatology - The Relaxin Gene Knockout ...
The Relaxin Gene Knockout Mouse: A Model of Progressive Scleroderma ..... Connetics Corporation, Palo Alto, California), were maintained in DMEM, ...
http://www.nature.com/jid/journal/v125/n4/full/5603548a.html...
|
Keith Chan, Ph.D. GloboAsia LLC 7250 Parkway Drive, Suite 340 ...
sclerosis with diffuse scleroderma and peripheral arterial disease. ... Connetics Corportation press release, “Connectics Names New Senior Vice
President ...
http://www.fda.gov/ohrms/dockets/dockets/95s0316/rpt0094_01....
|
Kidney International - Relaxin decreases renal interstitial ...
g/h; Connetics Corp., Palo Alto, CA, USA (Rlx)] or vehicle (20 mmol/L sodium .... In clinical trials in patients with scleroderma, relaxin has been found to
...
http://www.nature.com/ki/journal/v59/n3/full/4492102a.html...
|
New Applications for TNF Inhibition
Still's disease; Ankylosing spondylitis; Uveitis; Scleroderma ... Pharmacia Upjohn, Lilly, Connetics, Parke-Davis, Proctor & Gamble, Pfizer, ...
http://www.medscape.com/viewprogram/254_authors...
|
|
